N.Y. Group Buys 8.5% of Santa Monica Company
- Share via
A New York City partnership has acquired an 8.5% stake in International Genetic Engineering Inc. of Santa Monica and may seek to gain control of more shares either through open market transactions or a tender offer.
According to a filing with the Securities and Exchange Commission, Atalanta Selective Fund No. 6 bought 658,029 International Genetic common shares for about $1.9 million. Atalanta Selective’s general partners, Mark Newman and Atalanta Capital Corp., are seeking representation on the board of International Genetic, a research and development laboratory.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
